EFNB2 and head and neck squamous cell carcinoma: Several groups showed that the level of ephrin-B2 was significantly increased in head and neck squamous cell carcinoma (HNSCC) and that there was a correlation between elevated ephrin-B2 protein level and poor prognosis [12–15].